2-MORPHOLINOBENZYLAMINE – (204078-48-8)

268564-10-9, Fmoc-Arg(Me)2-OH, FMOC-ARG(ME2, ASYMMETRIC)-OH HCL, (2S)-5-[[amino(dimethylamino)methylidene]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)pentanoic acid, Fmoc-Nw, w-dimethyl-L-arginine (asymmetrical), Fmoc-ADMA hydrochloride salt, Fmoc-nomega, omega-dimethyl-L-arginine, MFCD00672718, Fmoc-Arg(Me)-OH (asymmetrical) hydrochloride salt, DTXSID40673979, Fmoc-Arg(Me)2-OH, asymmetrical, AKOS005063567, DS-9753, FF36547, Fmoc-N-omega, omega-dimethyl-L-arginine, (S)-12-(9H-fluoren-9-yl)-3-imino-2-methyl-10-oxo-11-oxa-2, 4, 9-triazadodecane-8-carboxylic acid, DB-027206, F12345, N-Fmoc-N', N'-dimethyl-L-arginine(asymmetrical), S-268564-10-9, N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-Nw, Nw-dimethyl-L-arginine, (2S)-5-[[Amino(dimethylamino)methylidene]amino]-2-Fmoc-amino-pentanoic acid, (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(3, 3-dimethylguanidino)pentanoic acid, (2S)-5-(N', N'-DIMETHYLCARBAMIMIDAMIDO)-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}PENTANOIC ACID, (E)-N~5~-[Amino(dimethylamino)methylidene]-N~2~-{[(9H-fluoren-9-yl)methoxy]carbonyl}-L-ornithine